Results 61 to 70 of about 13,396 (145)
Surface markers distinguishing mesenchymal stem cells from fibroblasts
Acta Medica Lituanica, 2012 Human mesenchymal stem cells (MSCs) are widely used for treatment of various diseases. Clinical applications require large quantities of MSCs, therefore these cells must be expanded in the culture system. It is believed that contamination of MSC cultures
Gabrielis KUNDROTAS
doaj +1 more source
Neoplasia: An International Journal for Oncology Research, 2004 Interactions between extracellular matrix proteins and prostate carcinoma cells change dramatically during prostate tumor progression. We have concentrated on two key modifications that occur in the hemidesmosome in prostate carcinoma: loss of laminin-5 ...
Robert Calaluce +7 more
doaj +1 more source
Actin Organization as an in Vitro Assay for Tumorigenicity [PDF]
, 1982 The endpoints of in vivo and in vitro assays applied to cells after exposure to a potential oncogenic transforming agent are cellular tumorigenicity and transformation.
Verderame, Michael +5 more
core +1 more source
Tumorigenicity of RTK/RAS in urothelium
Oncoscience, 2015 Although bladder cancer (BC) was the cancer from which the first human oncogene, RAS, was identified, questions persisted over the past 35 years as to whether RAS activation in urothelium was tumorigenic [1]. This was due in large part to the relatively low frequency (~15%) and lack of grade and stage association of RAS mutations in human BC [2 ...
Xue-Ru, Wu +2 more
openaire +2 more sources
Top networks of signature genes associated with tumorigenicity induced by KSHV miRs.
, 2013 Top networks of signature genes associated with tumorigenicity induced by KSHV miRs.
Roble Bedolla (502469) +8 more
core +1 more source
Citation: 'tumorigenic' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.16172 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire +1 more source
Tumorigenicity of aldehyde dehydrogenase 1 (ALDH1)-positive and ALDH1-negative cells in ACHN.
, 2013 Tumorigenicity of aldehyde dehydrogenase 1 (ALDH1)-positive and ALDH1-negative cells in ACHN.
Keita Todoroki (468007) +10 more
core +1 more source
Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer. [PDF]
, 2009 Cancer progression represents an evolutionary process where overall genome level changes reflect system instability and serve as a driving force for evolving new systems. To illustrate this principle it must be demonstrated that karyotypic heterogeneity (
Stevens, Joshua B. +15 more
core +1 more source
Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicity. [PDF]
, 2008 Human prostate cancer LNCaP cells including C-33 and C-81 cells were originally derived from the lymph nodes of a patient with metastatic prostate cancer. These two cells were employed for characterization of L-selectin ligand and in vitro tumorigenicity,
Lin, Ming-Fong +5 more
core +1 more source
Stem Cell Reports, 2016 The use of cells derived from pluripotent stem cells (PSCs) for regenerative therapies confers a considerable risk for neoplastic growth and teratoma formation.
Johannes Riegler +13 more
doaj +1 more source